Gali Prag, PhD
Gali Prag, PhD, Tel Aviv University, is a recipient of an ICRF Acceleration Grant. His research is focused on treating colorectal and other cancers by identifying drugs that will work together with the ubiquitin system (the body’s method of removing damaged proteins) to degrade specific proteins that may promote the development of cancer.
